BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3231568)

  • 1. Heterogeneity of the response to inducers of differentiation and to cytostatics of tumor cell populations.
    Pályi I
    Pathol Res Pract; 1988 Dec; 184(1):11-7. PubMed ID: 3231568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the sensitivity of retinoic acid sensitive and resistant HL-60 cell lines to several anti-leukemia drugs].
    Li L; Xia L; Han R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Dec; 16(6):469-72. PubMed ID: 7720148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
    Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
    Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemic cell maturation: variability of the myeloid leukemic cell phenotype.
    Ross DW; Pryzwansky KB; Prenant M; Dent G
    Blood Cells; 1986; 12(1):139-51. PubMed ID: 3466656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retinoic acid and 12-0-tetradecanoylphorbol-13-acetate (TPA) inducing bipotent differentiation of cultured primary bone marrow cells from leukemia patients].
    Chen ZX; Wu WL
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):26-9. PubMed ID: 1889336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
    Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
    J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells.
    Cellai C; Laurenzana A; Vannucchi AM; Della Malva N; Bianchi L; Paoletti F
    FASEB J; 2002 May; 16(7):733-5. PubMed ID: 11923217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of phorbol diester-induced HL-60-mediated cytotoxicity by retinoic acid, dimethyl sulfoxide, and 5-azacytidine.
    Leftwich JA; Hall RE
    Cancer Res; 1986 Aug; 46(8):3789-92. PubMed ID: 2425933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
    Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH
    Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S; Scher BM; Hellinger N; Scher W
    Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the c-fms oncogene in the regulation of HL-60 cell differentiation.
    Wu J; Zhu JQ; Han KK; Zhu DX
    Oncogene; 1990 Jun; 5(6):873-7. PubMed ID: 2141686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
    Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
    Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of simultaneous and sequential exposure to granulocytic and monocytic inducers on the choice of differentiation pathway in HL-60 promyelocytic leukemia cells.
    Zinzar S; Ohnuma T; Holland JF
    Leuk Res; 1989; 13(1):23-30. PubMed ID: 2915572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombomodulin induction by all-trans retinoic acid is independent of HL-60 cells differentiation to neutrophilic cells.
    Kizaki K; Ishii H; Horie S; Kazama M
    Thromb Haemost; 1994 Oct; 72(4):573-7. PubMed ID: 7878635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human promyelocytic HL60 cell line: a model of myeloid cell differentiation using dimethylsulphoxide, phorbol ester and butyrate.
    Ahmed N; Williams JF; Weidemann MJ
    Biochem Int; 1991 Feb; 23(3):591-602. PubMed ID: 1652248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipid- and Ca2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60.
    Zylber-Katz E; Glazer RI
    Cancer Res; 1985 Oct; 45(10):5159-64. PubMed ID: 3161611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
    Breitman TR; He RY
    Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of interleukin-1 beta gene expression during retinoic acid-induced granulocytic differentiation of promyeloid leukemia cells.
    Matikainen S; Tapiovaara H; Vaheri A; Hurme M
    Cell Growth Differ; 1994 Sep; 5(9):975-82. PubMed ID: 7819135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of differentiation-inducer-resistant HL-60 cells.
    Gallagher RE; Bilello PA; Ferrari AC; Chang CS; Yen RW; Nickols WA; Muly EC
    Leuk Res; 1985; 9(8):967-86. PubMed ID: 3862924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of differentiated functions in human melanoma cells by tumor-promoting agents and dimethyl sulfoxide.
    Huberman E; Heckman C; Langenbach R
    Cancer Res; 1979 Jul; 39(7 Pt 1):2618-24. PubMed ID: 445463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.